By vgreene, 27 May, 2015 Palivizumab prophylaxis not routinely recommended unless coexisting CHD/CLDP<sup>4</sup>
By vgreene, 27 May, 2015 Palivizumab prophylaxis not routinely recommended; may consider<sup>4</sup> if <12 mo old w/ impaired ability to clear lower airway secretions
By vgreene, 27 May, 2015 Palivizumab prophylaxis not routinely recommended; may consider<sup>4</sup> if <12 mo old and w/ CLD and/or nutritional compromise, or in 2nd yr of life if manifestations of severe lung dz<sup>7</sup> or weight for length <10th percentile
By vgreene, 27 May, 2015 Administer palivizumab<sup>4</sup> during 1st yr of life [B/M]; consider another season of palivizumab prophylaxis in the 2nd yr of life if pt continues to require medical support<sup>6</sup>
By vgreene, 27 May, 2015 Children <2 yo who undergo cardiac transplantation during RSV season may be considered for palivizumab prophylaxis
By vgreene, 27 May, 2015 If hemodynamically significant CHD,<sup>2,3</sup> administer palivizumab<sup>4</sup> during 1st yr of life, when <12 mo old at start of RSV season [B/S]
